Our third entry of "Best of UEG Week 2024" is all about "bench to bedside" world-class science! Interviewed by Julia Mayerle, Maria Del Pilar Acedo Nunez and Juozas Kupčinskas reflect on their highlights of the UEG Week 2024. Sessions and abstracts mentioned:

• Microbiota in diagnostics @03:35
• Microbiome: Bench to the future @03:35
• Pancreatic diseases: From mechanisms to therapy @04:05
• Session: IBD: Latest news on a personalised approach @05:25
• Session: Diagnose and treat to target in GI cancer: Latest news @05:25
• Pancreatic cancer: From bench to bedside @06:45
• FECAL MICROBIOTA TRANSPLANT VERSUS VANCOMYCIN FOR PRIMARY CLOSTRIDIODES DIFFICILE INFECTION – A RANDOMIZED NON-INFERIORITY TRIAL @08:50
• TARGETED FECAL MICROBIOTA TRANSPLANTATION IN PATIENTS RECEIVING PEMBROLIZUMAB PLUS AXITINIB FOR METASTATIC RENAL CELL CARCINOMA: PRELIMINARY RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (TACITO TRIAL) @09:05
• CROHN'S DISEASE AND ULCERATIVE COLITIS EXHIBIT PRE-DIAGNOSTIC ANTIBODY SIGNATURES WITH SHARED AND DIVERGENT CHANGES TOWARDS DISEASE ONSET @10:30
• Session: Understanding disease primers of IBD: Part 1
• Session: Understanding disease primers of IBD: Part 2
• Targeting kRAS in GI cancer @13:30
• SINGLE-NUCLEUS RNA SEQUENCING REVEALS THE CRUCIAL ROLE OF TERTIARY LYMPHOID STRUCTURES IN DRIVING B CELL MATURATION INTO PLASMA CELLS IN PDAC @14:30
• Never waste a good disaster: HPB @18:20